European Journal of Medical Research

European Journal of Medical Research is a peer-reviewed, fully open access journal founded in 1995 and published by BioMed Central, part of Springer Nature, encompassing translational and clinical research of international interest across all medical disciplines, with a 2025 Journal Impact Factor of 4.8.《欧洲医学研究杂志》（European Journal of Medical Research）是（BioMed Central）于 1995 年创办的同行评审完全开放获取期刊，现属施普林格自然（Springer Nature）集团，发表涵盖全部医学学科的国际关注的转化与临床研究，2025 年影响因子为 4.8。

Scope

• The journal encompasses translational and clinical research of international interest from across all medical disciplines, with a mission to enable clinicians and other researchers to learn about developments and innovations across subject-specific boundaries and between disciplines.该刊发表涵盖全部医学学科、具有国际关注的转化与临床研究，旨在帮助临床医生与其他研究者了解学科内部及跨学科的发展与创新。
• It welcomes high-quality research articles and reviews, independent of the outcome or significance of the findings.该刊欢迎高质量研究论文与综述，不以结果或显著性为取舍标准。
• Since a recent restructuring the journal is organised into six thematic sections, namely Circulation, Infection, Immunity and Inflammation, Metabolism and Reproductive Medicine, Neuroscience, Oncology, and Surgery and Therapeutic Innovation.经近期重组，该刊设为六个主题版块，即循环、感染免疫与炎症、代谢与生殖医学、神经科学、肿瘤学，以及外科与治疗创新。
• Each section is headed by a deputy editor supported by senior editors and a larger team of associate editors, and a dedicated deputy editor for reviews leads the reviews strategy.每个版块由一位副主编领衔，下有资深编辑与规模更大的副编辑团队，并设综述副主编专司综述策略。
• The journal is abstracted and indexed in MEDLINE and PubMed, PubMed Central, Scopus, EMBASE, the Science Citation Index Expanded and the Directory of Open Access Journals.该刊被（MEDLINE）与（PubMed）、（PubMed Central）、（Scopus）、（EMBASE）、科学引文索引扩展版及开放获取期刊目录（DOAJ）收录。
• The publisher reports a median of eight days from submission to first decision, and the journal passed 4.5 million downloads in 2025.出版方数据显示投稿至首次决定的中位时间为 8 天，该刊 2025 年下载量突破 450 万次。

History

• The journal was established in 1995 and began with volume 1, number 1 on 16 October 1995, founded by the Munich publishing house I. Holzapfel Verlag as a subscription print journal.该刊于 1995 年创办，1995 年 10 月 16 日以第 1 卷第 1 期开篇，由慕尼黑的（I. Holzapfel Verlag）创立，初为订阅制印刷期刊。
• Its early masthead listed Nepomuk Zollner of Munich as senior editor, and by 2011 the journal had several editors-in-chief including Dieter Haeussinger of Duesseldorf, while serving as an official organ of the German AIDS Society and the German Competence Network for HIV/AIDS.其早期刊头列慕尼黑的 Nepomuk Zollner 为资深编辑，至 2011 年已有多位主编，包括杜塞尔多夫的 Dieter Haeussinger，并一度担任德国艾滋病学会与德国艾滋病毒艾滋病能力网络的官方刊物。
• BioMed Central took over publishing with volume 14 in 2009, the print edition ceased with volume 16, number 12 in December 2011, and the first open access articles under BioMed Central appeared in January 2012, with the preceding three years of archive opened retroactively.（BioMed Central）自 2009 年第 14 卷起接手出版，印刷版止于 2011 年 12 月第 16 卷第 12 期，2012 年 1 月该刊在（BioMed Central）旗下发表首批开放获取论文，此前三年存档亦追溯开放。
• BioMed Central had been acquired by Springer in 2008, and the merged Springer Nature group was formed in 2015, under which the journal now operates as an online-only monthly title.（BioMed Central）于 2008 年被施普林格收购，2015 年合并组建施普林格自然集团，该刊现为该集团旗下的纯在线月刊。
• The journal is fully open access under the CC BY licence, with article processing charges reported at EUR 2590, USD 3090 or GBP 2190, and it celebrated its thirtieth anniversary in 2025.该刊以（CC BY）许可完全开放获取，文章处理费为 2590 欧元、3090 美元或 2190 英镑，并于 2025 年庆祝创刊三十周年。
• The 2025 Journal Impact Factor is 4.8, against 3.4 in 2024 and 4.981 in 2022, and Journal Citation Reports places the journal in Q2 of Medicine, Research and Experimental, ranked 55th of 191 titles.2025 年影响因子为 4.8，2024 年为 3.4，2022 年为 4.981，期刊引用报告将其列人医学研究与实验类 Q2 区，在 191 种期刊中排名第 55。

Editors

• The Editor-in-Chief is Adrian J.L. Clark, DSc, FMedSci, Emeritus Professor of Endocrinology at the University of London, whose career spans the William Harvey Research Institute and Barts and the London School of Medicine and Dentistry, Queen Mary University of London.主编 Adrian J.L. Clark 为伦敦大学内分泌学荣休教授，职业生涯横跨威廉·哈维研究所（William Harvey Research Institute）与伦敦玛丽女王大学巴茨与伦敦医学与牙科学院。
• His research has centred on the molecular genetic basis of hormone resistance syndromes and the actions of ACTH, and he previously edited the Journal of Endocrinology from 2009 to 2015, the Journal of Molecular Endocrinology from 2013 to 2015 and Endocrine Connections from 2020 to 2023.其研究聚焦激素抵抗综合征的分子遗传学基础与促肾上腺皮质激素的作用，曾于 2009 至 2015 年主编（Journal of Endocrinology）、2013 至 2015 年主编（Journal of Molecular Endocrinology），并于 2020 至 2023 年主编（Endocrine Connections）。
• The six thematic sections are led by deputy editors Chengming Fan of Central South University in Changsha, Andrea De Vito of the University of Sassari, Aleksandra Klisic of the University of Montenegro, Carlo Colosimo of LUM University in Italy, Jia Cheng of Zhongshan Hospital of Xiamen University and Filippo Migliorini of RWTH Aachen University.六大主题版块的副主编分别为中南大学的 Chengming Fan、萨萨里大学（University of Sassari）的 Andrea De Vito、黑山大学的 Aleksandra Klisic、意大利（LUM University）的 Carlo Colosimo、厦门大学中山医院的 Jia Cheng 与亚琛工业大学（RWTH Aachen University）的 Filippo Migliorini。
• Gaetano Isola was appointed Deputy Editor for Reviews, leading the journal's reviews strategy, and an editorial fellowship scheme supports early-career researchers.Gaetano Isola 获任综述副主编，主导该刊综述策略，早期职业研究者编辑计划（Editorial Fellowship Scheme）则为新人提供支持。
• Following triage, manuscripts receive external peer review by at least two independent reviewers with rounds of revision and re-review, and final decisions are taken at the senior editorial level to improve consistency and fairness.稿件经初步筛选后，由至少两位独立审稿人进行外部同行评审，并经历多轮修改与复审，最终决定由资深编辑层面作出，以提升一致性与公平性。